To investigate how OSM and IL-6 overexpression led to the increased fibrogenic response in bleomycin-induced fibrosis, we assessed pro-fibrotic and inflammatory mediators in the broncheoalveolar fluid (BALF) at day 7 after the administration of bleomycin and the adenovectors. This evidence concerns the gene IL6 and fibrosis.